Browse articles from EyeWorld.org on the topic of the cornea. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Meibomian gland dysfunction (MGD) is a broad term that covers various types of meibomian gland alterations. Vincent de Luise, MD, detailed the meibomian glands, how they differ in MGD, classification of MGD, and treatment options.
“Best practices are the summation of the technical aspects of medicine. They are, in effect, the perfection of the form of medicine,” said Julie Schallhorn, MD. She shared this and other thoughts on best practices and gave a preview of the articles in the Cornea section of the issue.
In a symposium at the 2023 ASCRS Annual Meeting, six cases with irregular corneas were presented and the panel was challenged to answer what would they do. This article gives an overview of those cases.
➤ Study: low-dose atropine doesn’t slow myopia progression ➤ Adverse events reported after use of FDA-approved geographic atrophy drug ➤ Phase 1 data for synthetic cannabinoid being investigated for glaucoma ➤ Enrollment complete in study evaluating topical diabetic retinopathy therapy ➤ Enrollment update for Phase 2b trial that could reduce AMD treatment burden ➤ ASCRS news and events
➤ Cataract surgery survey results ➤ FDA approves first non-degradable, synthetic tissue for ophthalmic surgery ➤ New cyclosporine ophthalmic solution approved for dry eye ➤ Results from Phase 2b study of drug-eluting contact lens ➤ 12-month topline data for intravitreal implant in wet AMD trial ➤ AAV capsid licensed for ocular gene therapy indication ➤ ASCRS news and events
➤ FDA approves new monofocal IOL ➤ Topline Phase 3 results for fixed-dose combination presbyopia drop ➤ Gene therapy trial produces positive Phase 1/2 data for Leber congenital amaurosis ➤ New data shows investigational compound protects endothelium for cataract patients undergoing Fuchs treatment ➤ ASCRS news and events
Amniotic membrane, in its various forms, has several ophthalmic applications, but it is also, at times, being marketed for indications that don’t have a lot of evidence in the scientific literature and/or that have other proven alternatives. Two ophthalmologists shared their experiences in this area.
When to refer, when to culture, treatment strategies, new treatment options, and more—EyeWorld spoke with two experts to get an update on the latest in corneal ulcer management.
➤ Fast-Track Designation granted for persistent epithelial defect treatment ➤ Study: automated capsulotomy device and white cataracts ➤ Dose escalation complete for Phase 1/2 study evaluating an RP treatment ➤ Companies enter agreement for sustained-release glaucoma treatment ➤ ASCRS news and events
Is DSAEK being taught less and less to surgeons in training in favor of DMEK? Three physicians shared their thoughts on the status of these two procedures in training programs and in practice.
Get the latest ophthalmology news delivered to your inbox every Friday.